Anne Sophie Geier

Dr. Anne Sophie Geier is the Managing Director at Spitzenverband Digitale Gesundheitsversorgung, Germany’s industry association for e-health. She studied pharmacy and completed her PhD in real-world evidence and outcomes research at WWU Münster and Harvard Medical School, and then worked in management consulting for a pharmaceutical company. Most recently, Anne was head of the department responsible for the early benefit assessment of newly authorised drugs at the GKV-Spitzenverband. She also has previous experience working as a consultant for Bayer Business Services and a Team Head for Benefit assessment of medicinal products for the National Association of Statutory Health Insurance Funds.